Market Research Logo

Global Companion Diagnostics Partnering 2010-2018: Deal trends, players and financials

Global Companion Diagnostics Partnering 2010-2018: Deal trends, players and financials

The Global Companion Diagnostics Partnering 2010-2018 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in companion diagnostics partnering deals
Companion diagnostics partnering agreement structure
Companion diagnostics partnering contract documents
Top companion diagnostics deals by value
Most active companion diagnostics dealmakers

The report provides a detailed understanding and analysis of how and why companies enter Companion Diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Companion Diagnostics agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Companion Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Companion Diagnostics partnering deals.

The report presents financial deal term values for Companion Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Companion Diagnostics partnering field; both the leading deal values and most active Companion Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 350 online deal records of actual Companion Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Companion Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Companion Diagnostics dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Companion Diagnostics deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Companion Diagnostics dealmaking with a brief summary followed by a comprehensive listing of Companion Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Companion Diagnostics partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Companion Diagnostics partnering deals signed and announced since Jan 2010. The chapter is organized by specific Companion Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Companion Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Companion Diagnostics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Companion Diagnostics technologies and products.

Key benefits

Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Companion Diagnostics deal trends since 2010
Access to headline, upfront, milestone and royalty data
Analysis of the structure of Companion Diagnostics agreements with numerous real life case studies
Detailed access to actual Companion Diagnostics contracts entered into by leading biopharma companies
Identify most active Companion Diagnostics dealmakers since 2010
Insight into terms included in a Companion Diagnostics partnering agreement, with real world examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Companion Diagnostics trends and structure of deals entered into by leading companies worldwide.

Companion Diagnostics Partnering Terms and Agreements includes:

Trends in Companion Diagnostics dealmaking in the biopharma industry since 2010
Analysis of Companion Diagnostics deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life Companion Diagnostics deals
Access to Companion Diagnostics contract documents
Leading Companion Diagnostics deals by value since 2010
Most active Companion Diagnostics dealmakers since 2010

In Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 350 Companion Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Companion Diagnostics dealmaking
    • Introduction
    • Companion Diagnostics partnering over the years
    • Most active Companion Diagnostics dealmakers
    • Companion Diagnostics partnering by deal type
    • Companion Diagnostics partnering by therapy area
    • Deal terms for Companion Diagnostics partnering
      • Companion Diagnostics partnering headline values
        • Table Companion Diagnostics deals with a headline value
      • Companion Diagnostics deal upfront payments
        • Table Companion Diagnostics deals with an upfront value
      • Companion Diagnostics deal milestone payments
        • Table Companion Diagnostics deals with a milestone value
      • Companion Diagnostics royalty rates
        • Table Companion Diagnostics deals with a royalty rate value
  • Leading Companion Diagnostics deals
    • Introduction
    • Top Companion Diagnostics deals by value
      • Table Top Companion Diagnostics deals by value since 2010
  • Most active Companion Diagnostics dealmakers
    • Introduction
    • Most active Companion Diagnostics dealmakers
    • Most active Companion Diagnostics partnering company profiles
      • Qiagen
      • Ventana Medical Systems
      • Dako
      • National Cancer Institute
      • Pfizer
      • Myriad Genetics
      • Roche
      • AstraZeneca
      • Foundation Medicine
      • Abbott Laboratories
      • Bristol-Myers Squibb
      • Clovis Oncology
      • Insight Genetics
      • Merck and Co
      • Leica Biosystems
      • Novartis
      • Thermo Fisher Scientific
      • Arno Therapeutics
      • Cell Signaling Technology
      • Eli Lilly
      • Illumina
      • MDxHealth
      • Amgen
      • Astellas Pharma
      • Biogen
  • Companion Diagnostics contracts dealmaking directory
    • Introduction
    • Companion Diagnostics contracts dealmaking directory
  • Companion Diagnostics dealmaking by technology type
    • Companion
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • Companion Diagnostics deals by company A-Z
      • 20/20 GeneSystems
      • AB-Biotics
      • Abbott Laboratories
      • Abbott Molecular
      • Abbvie
      • Abcam
      • AB Science
      • AccuGenomics
      • Achaogen
      • Acobiom
      • Advanced Biological Laboratories
      • Advanced Cell Diagnostics
      • Advanced Nuclear Medicine Ingredients
      • Advaxis
      • Aelan Cell Technologies
      • Aerocrine
      • AEterna Zentaris
      • Affymetrix
      • Agilent Technologies
      • Agios Pharmaceuticals
      • Akili Interactive Labs
      • Albert Einstein College of Medicine
      • Algeta
      • Almac Diagnostics
      • Almac Group
      • AltheaDX
      • Amarantus BioSciences
      • Ambit Biosciences
      • Amgen
      • Amoy Diagnostics
      • AmpliPhi Biosciences
      • AmpTec
      • Angle
      • Apogenix
      • ArcherDX
      • Ariad Pharmaceuticals
      • ARK Diagnostics
      • Arno Therapeutics
      • Array Biopharma
      • AssureRx Health
      • Astellas Pharma
      • Astellas Pharma US
      • Astex Pharmaceuticals
      • AstraZeneca
      • Astrimmune
      • Asuragen
      • Atherotech
      • Atossa Genetics
      • Aushon BioSystems
      • Australian Research Council
      • AVEO Oncology
      • Avila Therapeutics
      • Banner Sun Health Research Institute (BSHRI)
      • Bayer
      • Bayer Healthcare
      • BC Cancer Agency
      • Beckman Coulter
      • Becton Dickinson
      • BeiGene
      • BG Medicine
      • BioBay
      • Biocare Medical
      • Biocartis
      • Biocept
      • BioChain
      • Biodel
      • Biodesix
      • Biogen
      • Biognosys
      • BioImagene
      • BioMarin Pharmaceutical
      • BioMarker Strategies
      • Biomerica
      • BioMerieux
      • Biomoda
      • Bliss Biopharmaceutical
      • Blueprint Medicines
      • Boehringer Ingelheim
      • Bonnie J. Addario Lung Cancer Foundation
      • Bpifrance
      • Bristol-Myers Squibb
      • Bristol-Myers Squibb Pakistan
      • California NanoSystems Institute (CNSI)
      • Cambridge Biomedical
      • Canary Foundation
      • CANbridge Life Sciences
      • Cancer Genetics
      • Cancer Research Technology
      • Cancer Research UK
      • Cancer Treatment Centers of America
      • Carena
      • Caris Life Sciences
      • Case Western Reserve University
      • CDx Diagnostics
      • Cedars-Sinai Medical Center
      • Celgene
      • Celladon
      • Celldex Therapeutics
      • Cell Signaling Technology
      • Centre for Imaging Technology Commercialization
      • Centre National de la Recherche Scientifique
      • Cephalon
      • Cepheid
      • Cernostics
      • CHDI Foundation
      • Chembio Diagnostics
      • Chronix Biomedical
      • Chugai Pharmaceutical
      • Ci-Co Healthcare
      • Clarient
      • Clarity Pharmaceuticals
      • Clavis Pharma
      • Clevexel Pharma
      • Clinical Genomics
      • Clinical Reference Laboratory
      • Cloud Pharmaceuticals
      • Clovis Oncology
      • Columbia University
      • Columbia University Medical Center
      • CombiMatrix
      • Commercialisation Australia
      • CompanDX
      • Companion Dx Reference Lab
      • Companion Medical
      • Compendia Bioscience
      • Core Diagnostics India
      • Corgenix Medical
      • Cornell University
      • Covance
      • Cylene Pharma
      • Cynvenio
      • Dako
      • Dalton Pharma Services
      • Dana-Farber Cancer Institute
      • David H. Murdock Research Institute
      • Debiopharm
      • Definiens
      • Department of Defense
      • DermTech
      • DiagnoCure
      • DiamiR
      • Diaxonhit
      • Dimerix Biosciences
      • DxS
      • Eisai
      • Eli Lilly
      • Emory University
      • Empire Genomics
      • Endocyte
      • Enlyten Medical Technologies
      • Enterome Bioscience
      • Enzo Biochem
      • Epic Sciences
      • Epigenomics
      • Epitomics
      • Epizyme
      • Erytech
      • Eurofins Genomics
      • European Union Regional Development Fund
      • Eurotrans-Bio
      • Eutropics Pharmaceuticals
      • Evotec
      • Exact Sciences
      • EXINI Diagnostics
      • ExonHit Therapeutics
      • Exosome Diagnostics
      • Federal Ministry of Education and Research (BMBF)
      • FEI
      • Ferring Pharmaceuticals
      • Fibrocell Science
      • Five Prime Therapeutics
      • Flagship Biosciences
      • Foundation Medicine
      • Fox Chase Cancer Center
      • French National Research Agency
      • Fujirebio Diagnostics
      • Galena Biopharma
      • Galmed Pharmaceuticals
      • Geisinger Health System
      • Genentech
      • Generex Biotechnology
      • Genetic Technologies
      • Genmab
      • GenomeDx
      • Genomeon
      • Genome Diagnostics
      • Genomic Health
      • Genoptix
      • Genzyme
      • German Cancer Research Center
      • GE Healthcare
      • GI Pathology
      • GlaxoSmithKline
      • GlaxoSmithKline Biologicals
      • Glythera
      • Golden Helix
      • Guardant Health
      • HalioDx
      • Halozyme Therapeutics
      • Health Diagnostics Laboratory
      • Health Discovery
      • HistologiX
      • Hoffmann La Roche
      • Horizon
      • Horizon Discovery
      • Hospices Civils de Lyon
      • Hospital del Mar
      • HTG Molecular Diagnostics
      • Hybrigenics
      • Icon
      • IDbyDNA
      • Idera Pharmaceuticals
      • IDEXX Laboratories
      • Illumina
      • ImaginAb
      • Imanis Life Sciences
      • IMIDomics
      • ImmunID Technologies
      • ImmunoGen
      • ImmusanT
      • IncellDx
      • Incyte
      • Informed Data Systems
      • Inform Genomics
      • Innovate UK
      • Inotrem
      • Inova Diagnostics
      • Inserm Transfert
      • Insight Genetics
      • IntegraGen
      • Integrated Biobank of Luxembourg
      • International Cancer Genome Consortium
      • Intezyne
      • Invivis Pharmaceuticals
      • InVivoScribe
      • Ionis Pharmaceuticals
      • Ipsen
      • Ipsogen
      • IRCCS
      • Ironwood Pharmaceuticals
      • IRX Therapeutics
      • Janssen Biotech
      • Janssen Pharmaceutica NV
      • Jiangsu Hengrui Medicine
      • Johnson & Johnson Innovation
      • Johns Hopkins University
      • Kalgene Pharmaceuticals
      • KineMed
      • Kreatech
      • KSB Diagnostics
      • Lab21
      • Laboratory Corporation of America
      • Lehigh Valley Health Network
      • Leica Biosystems
      • Leica Microsystems
      • Life Technologies
      • Life Technologies Corporation
      • Locus Biosciences
      • London Genetics
      • Loxo Oncology
      • Luminex
      • Lumiphore
      • LUNGevity Foundation
      • Luye Pharma Group
      • Macquarie University
      • Macrogenics
      • Massachusetts General Hospital
      • Massachusetts Institute of Technology
      • Max Planck Institute for Infection Biology
      • Mayo Clinic
      • McKesson
      • MDxHealth
      • MD Anderson Cancer Center
      • Medco Health Solutions
      • Medical Prognosis Institute
      • Medivation
      • Med BioGene
      • Memorial Sloan Kettering Cancer Center
      • Merck and Co
      • Merck KGaA
      • Merck Serono
      • Merck Sharpe & Dohme
      • Merrimack Pharmaceuticals
      • Merus
      • Metamark Genetics
      • MetaStat
      • Michael J Fox Foundation
      • Mikrogen
      • Millennium
      • Millennium Medical Devices
      • Miragen Therapeutics
      • Mirati Therapeutics
      • MolecularMD
      • Montefiore Medical Center
      • Morphotek
      • MWI Veterinary Supply
      • Myriad Genetics
      • NanoString Technologies
      • National Cancer Institute
      • National Center for Drug Screening
      • National Heart, Lung and Blood Institute
      • National Institutes of Health
      • National Institute of Diabetes and Digestive and Kidney Diseases
      • National Science Foundation
      • Nemucore Medical Innovations
      • Neogenix Oncology
      • Neogenomics
      • Networking Biomedical Research Centre in Liver and Digestive Diseases (CIBEREHD)
      • NeuroMetrix
      • Newcastle University
      • New Liberty Proteomics
      • New York University
      • Nexpep
      • Nicholas Conor Institute for Pediatric Cancer Research
      • Nihon Medi-Physics
      • Nipro Diagnostics
      • Nodality
      • North Carolina State University
      • Novartis
      • NovioGendix
      • Nuclea Biotechnologies
      • NuSirt
      • OcellO
      • On-Q-ity
      • Oncology Venture
      • OncoMed Pharmaceuticals
      • One Way Liver Genomics (OWL)
      • Ono Pharmaceutical
      • Ontario Cancer Biomarker Network
      • Ontario Institute for Cancer Research
      • OPKO Health
      • Oridis Biomarkers
      • Ortho-Clinical Diagnostics
      • OSEO
      • OSI Pharmaceuticals
      • Oxford BioMedica
      • Oxford Gene Technology
      • OxOnc Development
      • Paradigm
      • Patrys
      • Peking University Cancer Hospital
      • Penn State Hershey
      • PerkinElmer
      • Personal Genome Diagnostics
      • Pfizer
      • Pharmacyclics
      • PharmaMar
      • Photocure ASA
      • Pierre Fabre
      • Piramal Imaging
      • Precision Therapeutics
      • Primeradx
      • Profusa
      • Protagen
      • Proteomics International
      • Q2 Solutions
      • Qiagen
      • QIAGEN (Suzhou) Translational Medicine Center
      • Quest Diagnostics
      • Quintiles
      • Q BioMed
      • R-Biopharm
      • RedHill Biopharma
      • Regulus Therapeutics
      • ResearchDx
      • Research Institute of the Hospital Universitari Vall d'Hebron
      • Respira Health
      • Roche
      • Roche Diagnostics
      • Roche Molecular Systems
      • Rush University Medical Center
      • Saladax Biomedical
      • Salix Pharmaceuticals
      • Samsung Medical Center
      • Sanofi
      • San Raffaele Scientific Institute
      • Scancell
      • Seattle Genetics
      • Seegene
      • Seoul National University
      • Serametrix
      • Servier
      • Shanghai Pharmaceuticals Holdings
      • Shuwen Biotech
      • Siemens Healthcare
      • Siemens Healthcare Diagnostics
      • Singapore Radiopharmaceuticals
      • Singulex
      • Sirius Genomics
      • Small Business Innovation Research
      • Smart Personalized Medicine
      • Source Bioscience
      • Spectrum Pharmaceuticals
      • Splicos
      • SRL
      • Stallergenes
      • Strata Oncology
      • Summit Pharmaceuticals
      • Sunnybrook Health Sciences Centre
      • SuperNova Diagnostics
      • Syapse
      • Syndax Pharmaceuticals
      • Synthon
      • Sysmex Inostics
      • Takeda Pharmaceutical
      • TcLand Expression
      • Technology Strategy Board (UK)
      • Technology Transfer Accelerator
      • Telix Pharmaceuticals
      • Tesaro
      • Theradiag
      • Thermo Fisher Scientific
      • The Fleury Group
      • Threshold Pharmaceuticals
      • Tocagen
      • Tokai Pharmaceuticals
      • Tolero Pharmaceuticals
      • TRACON Pharmaceuticals
      • Transgene
      • Transgenomic
      • Translational Drug Development
      • UCB
      • Unilabs
      • University College London
      • University Health Network
      • University of Barcelona
      • University of Bonn
      • University of California, San Diego
      • University of California Los Angeles
      • University of Central Florida Research Foundation
      • University of Colorado Denver
      • University of Kansas
      • University of Minnesota
      • University of North Texas Health Science Center
      • University of Pennsylvania
      • University of Pennsylvania School of Veterinary Medicine
      • University of Pittsburgh Cancer Institute
      • University of Tokyo
      • University of Washington
      • USBiomarkers
      • ValiRx
      • Van Andel Institute
      • Vector Oncology
      • Vela Diagnostics
      • Ventana Medical Systems
      • Veracyte
      • Verastem
      • Veridex
      • Vertex Pharmaceuticals
      • ViiV Healthcare
      • ViroMed
      • Virovek
      • VuCOMP
      • Vyriad
      • Wake Forest University School of Medicine
      • Whitehead Institute
      • WuXi NextCODE Genomics
      • XDx
      • Xenon Pharmaceuticals
      • Yale University
      • Zinfandel Pharmaceuticals
      • Zora Biosciences
    • Companion Diagnostics deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Companion Diagnostics deals by deal type
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Marketing
      • Material transfer
      • Option
      • Promotion
      • Research
      • Settlement
      • Sub-license
      • Supply
      • Technology transfer
      • Termination
    • Companion Diagnostics deals by therapy area
      • Breast
      • Lump
      • Cardiovascular
      • Congestive heart failure
      • Central Nervous System
      • Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease)
      • Multiple sclerosis
      • Pain
      • Parkinson's disease
      • Dermatology
      • Itching
      • Psoriasis
      • Gastrointestinal
      • Celiac disease
      • Esophageal reflux
      • Inflammatory bowel disease
      • Crohn's disease
      • Ulcerative colitis
      • Irritable bowel syndrome
      • Constipation
      • Genetic disorders
      • Huntington's disease
      • Chronic kidney disease (CKD)
      • Infertility
      • Hematology
      • Hospital care
      • Poisoning
      • Transplantation
      • Immunology
      • AIDS
      • Other autoimmune
      • Inflammation
      • Systemic lupus erythematosus
      • Infectives
      • Bacterial
      • Lyme disease
      • Mycobacterium avium
      • Pseudomonas aeruginosa
      • Sepsis
      • Tuberculosis (TB)
      • Cytomegalovirus
      • HIV
      • Metabolic
      • Diabetes
      • Fatty liver
      • Nonalcoholic steatohepatitis (NASH)
      • Musculoskeletal
      • Rheumatoid arthritis
      • Obstetrics
      • Oncology
      • Basal cell carcinoma
      • Bladder cancer
      • Bone cancer
      • Brain cancer
      • Breast cancer
      • Colorectal cancer
      • Endometrial
      • Esophageal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic lymphocytic leukemia
      • Chronic myelogenous leukemia
      • Lung cancer
      • Non small cell lung cancer
      • Lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Mesothelioma
      • Metastases
      • Multiple myeloma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Sarcoma
      • Solid tumors
      • Thyroid cancer
      • Ophthalmics
      • Glaucoma
      • Pediatrics
      • Psychiatry
      • Cognitive impairment
      • Alzheimers
      • Depression
      • Schizophrenia
      • Obesity
      • Respiratory
      • Asthma
      • Chlamydia
      • Gonorrhea
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report